Artificial Minitransposon Used to Create Protein Mutation Expression Library
By LabMedica International staff writers Posted on 20 Feb 2012 |

Image: 3D ribbon-drawing of a hypothetical circularly permuted protein (Photo courtesy of Rice University).
An efficient new method for producing mutated-protein expression libraries provides unique benefits for protein structure-function studies and for protein engineering.
The minitransposon was specifically designed and used, by random insertion via the MuA transposase enzyme, to create a gene library for expressing a set of protein mutants that provides distinct protein sequence diversity over existing methods.
Libraries expressing multiple mutants of a given protein are particularly useful for studying protein mechanisms and the adaptation of proteins during molecular evolution, as well as for designing proteins (such as biosensors and molecular switches) with novel functions in synthetic biology, including potential drug therapy enzymes.
One type of library in use is made up of "circularly permuted" protein mutants, proteins that have been mutated by connecting the two ends (the N- and C-termini) and later breaking elsewhere, often also having altered part(s) in between.
The new method, called PERMutation Using Transposase Engineering (PERMUTE), for making this type of library was developed by senior undergraduate student Manan Mehta and mentor Jonathan Silberg, assistant professor, at Rice University's Department of Biochemistry and Cell Biology (Houston, TX, USA), with assistance from research technician and coauthor Shirley Liu.
"Creating such a library has traditionally required painstaking processes," said Prof. Silberg. "Existing methods for rearranging the bits of information in a protein are slow and arduous to use," he said. "In addition, they are nonideal because they simultaneously create multiple types of mutations, the desired rearrangements, and undesired deletions of important amino acids.”
Prof. Silberg further explained, "With our method, you only generate mutants with rearranged sequences, and you don't need to be an expert in biomolecular engineering. All you need is the DNA that encodes your gene of interest, the artificial minitransposon we engineered and an enzyme. […] It's a way of making, with great control, all of the diversity of this type of mutation that could exist in a protein."
In this particular study, published online ahead of print on February 7, 2012, in the journal Nucleic Acids Research, a library was created where the enzyme adenylate kinase was mutated. The library of mutant proteins was then mined for variants that retained catalytic functional by introducing them into Escherichia coli bacteria then screening and selecting for adenylate kinase activity. Out of about 220 sequenced mutants (about half of which were active), 15 unique sequence variants were identified.
The work was supported by the National Aeronautics and Space Administration (NASA; USA) and the Robert A. Welch Foundation (The Welch Foundation; Houston, TX, USA).
Related Links:
Rice University
The minitransposon was specifically designed and used, by random insertion via the MuA transposase enzyme, to create a gene library for expressing a set of protein mutants that provides distinct protein sequence diversity over existing methods.
Libraries expressing multiple mutants of a given protein are particularly useful for studying protein mechanisms and the adaptation of proteins during molecular evolution, as well as for designing proteins (such as biosensors and molecular switches) with novel functions in synthetic biology, including potential drug therapy enzymes.
One type of library in use is made up of "circularly permuted" protein mutants, proteins that have been mutated by connecting the two ends (the N- and C-termini) and later breaking elsewhere, often also having altered part(s) in between.
The new method, called PERMutation Using Transposase Engineering (PERMUTE), for making this type of library was developed by senior undergraduate student Manan Mehta and mentor Jonathan Silberg, assistant professor, at Rice University's Department of Biochemistry and Cell Biology (Houston, TX, USA), with assistance from research technician and coauthor Shirley Liu.
"Creating such a library has traditionally required painstaking processes," said Prof. Silberg. "Existing methods for rearranging the bits of information in a protein are slow and arduous to use," he said. "In addition, they are nonideal because they simultaneously create multiple types of mutations, the desired rearrangements, and undesired deletions of important amino acids.”
Prof. Silberg further explained, "With our method, you only generate mutants with rearranged sequences, and you don't need to be an expert in biomolecular engineering. All you need is the DNA that encodes your gene of interest, the artificial minitransposon we engineered and an enzyme. […] It's a way of making, with great control, all of the diversity of this type of mutation that could exist in a protein."
In this particular study, published online ahead of print on February 7, 2012, in the journal Nucleic Acids Research, a library was created where the enzyme adenylate kinase was mutated. The library of mutant proteins was then mined for variants that retained catalytic functional by introducing them into Escherichia coli bacteria then screening and selecting for adenylate kinase activity. Out of about 220 sequenced mutants (about half of which were active), 15 unique sequence variants were identified.
The work was supported by the National Aeronautics and Space Administration (NASA; USA) and the Robert A. Welch Foundation (The Welch Foundation; Houston, TX, USA).
Related Links:
Rice University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more